Indeed, they considered that inhibition of VEGFR and EGFR was relevant to the function of the genetically modified T cells, favoring tumor infiltration, reducing the immunosuppressive status of the tumor microenvironment, and down-modulating PD-L1 expression in the cancer cells. The gene discussed is KDR; the disease is neoplasm.